Clalit
Clalit Health Services to join European AI research project predicting, managing pandemics
Clalit Health Services will join an international consortium of health authorities to create an AI research platform to predict and manage pandemics in advance.
'You Arabs should not be here': Suspect arrested for spitting at, threatening pharmacist
Groundbreaking in utero surgery performed for first time by Israeli doctors in Petah Tikva
Air pollution and extreme heat linked to more migraine attacks, Israeli study finds
Healthcare 2040: Could doctors predict your medical future?
Effectively collaborating with computers could help reduce errors and allow healthcare to shift from supplying patient-level, reactive therapeutics to predictive, proactive and preventative care.
Paxlovid reduces risk of COVID-19 death by 81%, Clalit study shows
So far, over 30,000 COVID-19 patients in Israel have been treated with the anti-viral Paxlovid drug.
Fourth coronavirus vaccine dose lowers mortality risk fourfold - study
Patients who received the fourth dose were 76% less likely to die compared to those who received just the third dose.
Essence Group - Providing innovative personal protection technologies globally
Essence Group, is a leading technology company, which develops cloud-based, end-to-end security and healthcare solutions that protect people while they’re at work and at home.
Essence SmartCare, Sharan Medical Care launch medical monitoring project
The pilot project is a collaboration between Essence SmartCare, Clalit Health Services and Sharan Medical Care and can reduce hospital occupancy during the COVID-19 pandemic and beyond.
Technion students developed digital tools to improve patients' knowledge
Two Technion PhD students have created animated explanatory videos to educate patients on genetic counseling, giving patients access to the knowledge needed to make informed decisions.
'Plausible connection' between COVID-19 vaccine and period changes
Doctors say that even if the vaccine does have an impact on menstruation, it is short-term and the vaccine does not affect fertility.
COVID: Mild cases at risk of deterioration to be given antibody drug
Regeneron was authorized in November for emergency use by the US Food and Drug Administration (FDA).
COVID: 3rd vaccine in immunosuppressed patients works – Israeli hospital
Some 73% of organ transplant patients who received a third coronavirus vaccine developed antibodies compared to only 35% after the second vaccine, according to new research.
UAE Ambassador to Israel visits children's hospital after normalization
Thanks to the Abraham Accords, Israeli and Emirati insurance companies are working together to build a healthier Middle East.
